Glenmede Trust’s MarineMax HZO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-435
Closed -$11K 1692
2020
Q3
$11K Buy
435
+217
+100% +$5.97K ﹤0.01% 1835
2020
Q2
$4K Buy
218
+40
+22% +$658 ﹤0.01% 2125
2020
Q1
$2K Hold
178
﹤0.01% 2859
2019
Q4
$2K Sell
178
-447
-72% -$7.29K ﹤0.01% 2859
2019
Q3
$8K Sell
625
-22
-3% -$336 ﹤0.01% 2448
2019
Q2
$10K Hold
647
﹤0.01% 2369
2019
Q1
$11K Hold
647
﹤0.01% 2324
2018
Q4
$11K Buy
+647
New +$13.5K ﹤0.01% 2229
2015
Q3
Sell
-100
Closed -$2K 2765
2015
Q2
$2K Hold
100
﹤0.01% 2438
2015
Q1
$2K Buy
100
+50
+100% +$1.22K ﹤0.01% 2359
2014
Q4
$1K Hold
50
﹤0.01% 2462
2014
Q3
$0 Buy
+50
New +$868 ﹤0.01% 2482
2014
Q1
Sell
-50
Closed 2355
2013
Q4
$0 Hold
50
﹤0.01% 2303
2013
Q3
$0 Hold
50
﹤0.01% 2234
2013
Q2
$0 Buy
+50
New +$606 ﹤0.01% 2165

Other funds holding HZO

Glenmede Trust's HZO Position: Q4 2020 in Review

Glenmede Trust sold out of MarineMax (HZO) in Q4 2020, closing a stake of 435 shares — an estimated $11K sold.

Glenmede Trust first reported a position in HZO in Q2 2013 and held it in 15 quarters. The position peaked at $11K in Q3 2020. 185 funds tracked by Wall St. Rank hold HZO as of Q4 2020.

  • Glenmede Trust reported no remaining MarineMax position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 435 MarineMax shares in Q4 2020, an estimated $11K.
  • Glenmede Trust first reported a position in MarineMax in Q2 2013 and held it in 15 quarters.
  • Glenmede Trust's MarineMax position peaked at $11K in Q3 2020.
  • 185 funds tracked by Wall St. Rank held MarineMax as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.